SecBot SecBot

SERA

SERA PROGNOSTICS, INC.
Nasdaq· Services-Medical Laboratories· Inc. DE· CIK 0001534969 Healthcare & Medical Devices
$2.08 +0.05 (+2.46%)
Oct 26 4:00 PM ET · prev $2.03
Market cap
$80.5M
Micro cap
Median target
$5.50
+164% · range $5.00–6.00
Next earnings
Nov 4
in 9 days · EPS est. −$0.14
1 year
−44.4%
from $3.74 · Oct 27
30 days
+3.0%
from $2.02
52-week range
$1.59–3.75
−45% from high · low May 13
Avg volume 20D
13.1K
shares / day
Short interest
229.7K
≈0.6% of shares · +7.4%
Days to cover
13.4
at average volume
Insider net
−$170.2K
0 buyers · 6 sellers · since Mar 12
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
11
analyzed by SecBot
SecBot read MIXED 3 reports · 90 days
Balance 0 bearish · 0 bullish · 3 neutral oldest → newest, height = score
Avg score ·High conf. 3/3 ·Next Earnings date, Nov 4, 2026
Strongest NEUTRAL Officer Tiffany Inglis filed a Form 144 notice of intent to sell 8,024 shares of Sera Prognostics Class A…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

  • A Jun 4 Craig-Hallum initiates
  • S Jun 8 to Jun 11 3 days of insider sells: $90.6K by 6 insiders, avg $2.06
  • S Sep 8 to Sep 10 2 days of insider sells: $63.3K by 4 insiders, avg $2.00
  • S Oct 12 1 insider sell $16.3K at $2.03

Signal stack

Where each data set points today.

  • InsidersBEARISH

    6 insiders sold $170.2K.

  • InstitutionsMIXED

    Q2 2026: 3 added (0 new), 5 trimmed or exited.

  • EstimatesRISING

    Current-quarter EPS estimate −$0.170 → −$0.140 over 90 days. 2 up, 0 down in 30 days.

  • Short sellersSTEADY

    Short interest +7.4% to 229.7K shares. 13.4 days to cover, ≈0.6% of shares.

  • TrendRANGE

    1% above its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
NORTHERN TRUST CORPTRIM68,595$124.8K
MORGAN STANLEYTRIM50,972$92.8K
Qube Research & Technologies LtdDOUBLED50,871$92.6K
CITADEL ADVISORS LLCNEAR_EXIT41,411$75.4K
GOLDMAN SACHS GROUP INCADD32,541$59.2K
DIMENSIONAL FUND ADVISORS LPADD29,499$53.7K
BARCLAYS PLCNEAR_EXIT3,179$5.8K
FMR LLCTRIM2,539$4.6K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Jun 2026
12-month targets · 2 analysts

Price is below the lowest target. Median implies +164%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
Jun 4, 2026Craig-Hallum
INITIATE
INITIATEBuy

Insider ledger

Form 4
$0
bought · 0 insiders
$170.2K
sold · 6 insiders
DateInsiderTypeValue
Oct 12, 2026
Inglis Tiffany Eul Davis
Chief Medical Officer
SELL$16.3K
Sep 10, 2026
Jackson Benjamin
General Counsel
SELL$4.4K
Sep 10, 2026
Lindgardt Zhenya
Chief Executive Officer
SELL$14.0K
Sep 10, 2026
Anderson Dyaarl Lee Jr.
Chief Commercial Officer
SELL$3.6K
Sep 10, 2026
Inglis Tiffany Eul Davis
Chief Medical Officer
SELL$972.00
Sep 8, 2026
Lindgardt Zhenya
Chief Executive Officer
SELL$40.3K
Aug 31, 2026
Gleason Scott
Chief Financial Officer
AWARD117,924 sh
Aug 31, 2026
Gleason Scott
Chief Financial Officer
AWARD169,624 sh

Earnings setup

Estimates
Nov 4
reports in 9 days
−$0.14
EPS estimate, this quarter
+18%
estimate change, 90 days
2↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.14-$0.18–-$0.10+16.0%$75.0K
Next Q-$0.17-$0.21–-$0.14+8.9%$125.0K
Current FY-$0.66-$0.72–-$0.62+3.3%$225.0K
Next FY-$0.54-$0.55–-$0.52+7.2%$1.9M

Short side

FINRA· Sep 30, 2026
229,723
shares short
+7.4%
vs prior settlement
13.4
days to cover
≈0.6%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 21, 2026 SEC
Sera Prognostics, Inc. announced it will host a conference call on November 4, 2026 to discuss its fiscal Q3 2026…
PRESS-RELEASE — Impact 1/10
Oct 21, 2026 Earnings
SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF THIRD QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON NOVEMBER 4, 2026
SALT LAKE CITY, Oct. 21, 2026 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq:
Oct 13, 2026 SEC
Officer Tiffany Inglis filed a Form 144 notice of intent to sell 8,024 shares of Sera Prognostics Class A Common…
144 — Impact 2/10
Oct 12, 2026 Insider
Inglis Tiffany Eul Davis sold 8,024 shares
Chief Medical Officer @ $2.03 ($16.3K)
Sep 10, 2026 Insider
Jackson Benjamin sold 2,190 shares
General Counsel @ $2.00 ($4.4K)
Sep 10, 2026 Insider
Lindgardt Zhenya sold 7,022 shares
Chief Executive Officer @ $2.00 ($14.0K)
Aug 19, 2026 SEC
Sera Prognostics announced a planned CFO succession: Austin Aerts steps down effective August 31, 2026, and Scott…
8-K — Impact 3/10
Jun 30, 2026 Inst.
NORTHERN TRUST CORP — TRIM
68,595 shares ($124.8K)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 4, 2026
Earnings date
SERA Q3 2026 Earnings Scheduled — 2026-11-04
Recent
Oct 21, 2026
Earnings
SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF THIRD QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON NOVEMBER 4, 2026
SALT LAKE CITY, Oct. 21, 2026 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and…
Aug 19, 2026
Press release
SERA PROGNOSTICS APPOINTS SCOTT GLEASON CHIEF FINANCIAL OFFICER
SALT LAKE CITY, Aug. 19, 2026 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and…
Aug 12, 2026
Earnings
SERA PROGNOSTICS REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS
SALT LAKE CITY, Aug. 12, 2026 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and…
Aug 12, 2026
Earnings date
SERA Q2 2026 Earnings Scheduled — 2026-08-12
Aug 4, 2026
Earnings date
SERA Q2 2026 Earnings Scheduled — 2026-08-04

SecBot reports

11 filings · 0 bullish · 1 bearish · 10 neutral
All SERA filing & press-release reports (11)